Citadel Advisors’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $28.6M | Sell |
|
|||||
|
2024
Q4 | $47.1M | Buy |
|
|||||
|
2024
Q3 | $6.19M | Sell |
|
|||||
|
2024
Q2 | $20.6M | Buy |
|
|||||
|
2024
Q1 | $19.5M | Buy |
|
|||||
|
2023
Q4 | $2.54M | Sell |
|
|||||
|
2023
Q3 | $7.93M | Sell |
|
|||||
|
2023
Q2 | $28.2M | Buy |
|
|||||
|
2023
Q1 | $17.4M | Buy |
|
|||||
|
2022
Q4 | $7.49M | Sell |
|
|||||
|
2022
Q3 | $6.39M | Buy |
|
|||||
|
2022
Q2 | $3.58M | Sell |
|
|||||
|
2022
Q1 | $8.2M | Buy |
|
|||||
|
2021
Q4 | $3.86M | Buy |
|
|||||
|
2021
Q3 | $1.57M | Sell |
|
|||||
|
2021
Q2 | $1.26M | Sell |
|
|||||
|
2021
Q1 | $1.68M | Buy |
|
|||||
|
2020
Q4 | $997K | Sell |
|
|||||
|
2020
Q3 | $7.45M | Buy |
|